STEMINA BIOMARKER DISCOVERY, INC.

Company Information

Company Name
STEMINA BIOMARKER DISCOVERY, INC.
Address
504 S. Rosa Road
MADISON, WI, 53719-1256
Phone
1 608-204-0104
URL
n/a
DUNS
794516695
Number of Employees
11
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$445,449.00
3
SBIR Phase II
$1,499,936.00
2
Chart code to be here

Award List

  1. Not Available

    Amount: $999,936.00

    Brain tumor stem cells (BTSCs) are a subset population within tumors that are widely believed to be  responsible for tumor recurrence, due to their ability to self-renew, differentiate, migrate, ...

    SBIR Phase II 2010 Department of Health and Human Services
  2. SBIR Phase I: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model

    Amount: $149,255.00

    This Small Business Innovation Research (SBIR) Phase I project proposes to develop a highly predictive model for assessing the potential of compounds to cause birth defects in the developing human emb ...

    SBIR Phase I 2009 National Science Foundation
  3. SBIR TOPIC 245 "PREDICTIVE EFFICACY SCREENING IN CANCER STEM CELLS USING METABOLO

    Amount: $149,528.00

    Cancer stem cells (CSCs) are a critical tumor subpopulation that may cause local recurrences that plague patients with advanced solid malignancies, even after maximal therapeutic efforts. CSCs can sel ...

    SBIR Phase I 2008 Department of Health and Human Services
  4. SBIR Phase II: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model

    Amount: $500,000.00

    This Small Business Innovation Research (SBIR) Phase II project will fund a continuation of breakthrough research, development and commercialization of an in vitro assay to help prevent birth defects. ...

    SBIR Phase II 2011 National Science Foundation
  5. Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Plurip

    Amount: $146,666.00

    DESCRIPTION (provided by applicant): Cardiotoxicity, as a result of adverse drug effects, is a serious problem that has yet to be effectively screened prior to patient exposure. Cardiac safety is one ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government